Skip to main content
U.S. flag

An official website of the United States government

Return to Search

Pub 100-02 Medicare Benefit Policy: Automated Multi-Channel Chemistry (AMCC) for Continuous Ambulatory Peritoneal Dialysis (CAPD) and Non-CAPD Patients

Guidance presenting corrections to the Internet Only Manual for payment policy to indicate the End Stage Renal Disease-related Automated Multi-Channel Chemistry (AMCC) tests that are included in the composite rate for Continuous Ambulatory Peritoneal Dialysis (CAPD) and Non-CAPD patients, in accordance with previously issued intermediary billing guidelines.

Download the Guidance Document

Final

Issued by: Centers for Medicare & Medicaid Services (CMS)

Issue Date: June 03, 2005

DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.